Molcure

Provider of AI-based platform for drug discovery and design

placeTokyo, Tokyo, Japan calendar_todayFounded 2013 groups33 employees language molcure.com

Innovation

3 patent families (1 granted) — focus: Physics & computing, Human necessities; filing pace slowing. Cited 67 times.

YearFilings
20153
20162
20171
20191
20201
20211

Social engagement

Social engagement: 745 social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Dai-Ichi Life, GMO Venture Partners, Nippon ChemiPhar, JAFCO Group.

Investor typeCountShare
Venture capital444%
Private equity111%
Accelerator & incubator111%
Other / undisclosed333%

Recent activity

15 Jun 2026
Event
BIO 2026
15 Jun 2026
Event
BIO 2026
7 Jun 2026
Event
Illumina Webinar
Coming soon